| Rank | Broker Platform | Rating | Key Execution Features | BMY Trading Fee | Access |
|---|---|---|---|---|---|
| #01 |
Top Choice
Earn
|
9.9/10
|
Zero Commission BMY Instant Orders Automated Dividends |
$0.00
No minimum
|
Trade BMY |
| #02 |
Interactive Brokers
|
9.7/10
|
SmartRouting Engine Deep Research |
$0.005
Per share (IBKR Lite $0)
|
View Broker |
| #03 |
Charles Schwab
|
9.6/10
|
thinkorswim Tools Schwab Stock Slices |
$0.00
Zero commission
|
View Broker |
| #04 |
Fidelity Investments
|
9.5/10
|
No PFOF on Equity Fractional Shares |
$0.00
Zero commission
|
View Broker |
| #05 |
eToro
|
9.4/10
|
Social Sentiment 0% Stock Markups |
$0.00
$10 min deposit
|
View Broker |
| #06 |
Webull
|
9.3/10
|
Full Premarket / After-Hours Level 2 Quotes |
$0.00
$0 min deposit
|
View Broker |
| #07 |
Robinhood
|
9.2/10
|
DRIP Auto-Reinvest 24-Hour Market |
$0.00
Zero fee
|
View Broker |
| #08 |
TD Ameritrade
|
9.1/10
|
Thinkorswim Tools Options Analytics |
$0.00
Zero commission
|
View Broker |
| #09 |
Hargreaves Lansdown
|
9.0/10
|
UK Stocks & ISAs DRIP Tracking |
£12.50
0.5%–1% FX fee
|
View Broker |
| #10 |
Morningstar
|
8.9/10
|
Fair Value Rating Biopharma Peers |
Free / $0
Research platform
|
Research BMY |
Top 3 BMY Stock Brokers in Detail
In-depth breakdown of the leading platforms for executing Bristol-Myers Squibb (BMY) trades, managing dividend reinvestment, and leveraging professional market analytics.
Earn delivers an ultra-streamlined, fully regulated mobile trading experience tailored for equity investors. With zero commissions on NYSE-listed Bristol-Myers Squibb (BMY), instantaneous order routing, automated dividend reinvestment (DRIP), and intuitive mobile charting, it stands as the premier choice for both active traders and long-term pharmaceutical portfolio holders.
Key Advantages
- 0% commission on BMY stock trades & $0 minimum deposit
- Fully regulated broker with an intuitive iOS & Android app
- Automatic quarterly BMY dividend reinvestment (DRIP) support
Considerations
- Advanced multi-leg options require the desktop interface
- Limited legacy paper statement delivery options
Interactive Brokers offers direct market access and institutional-grade order execution via SmartRouting. Ideal for quantitative analysis on Bristol-Myers Squibb's pharmaceutical pipeline, it provides deep Level II liquidity, comprehensive analyst forecasts, and competitive margin financing for active healthcare investors.
Key Advantages
- SmartRouting engine ensures optimal price fills across US exchanges
- Institutional-grade fundamental analysis & biopharma metrics
- IBKR Lite plan features $0 commission US stock trading
Considerations
- Trader Workstation (TWS) has a steep initial learning curve
- Advanced live market data feeds may require monthly add-ons
Charles Schwab unites commission-free US equity trading with powerhouse thinkorswim charting capabilities. Investors targeting BMY stock benefit from fractional trading via Schwab Stock Slices starting at $5, extensive biopharma market coverage, and reliable 24/7 customer assistance.
Key Advantages
- $0 commission on all online US stock and ETF orders
- Schwab Stock Slices allow fractional BMY purchases from $5
- Award-winning thinkorswim platform included at no extra cost
Considerations
- International exchange access requires specialized global accounts
- Default uninvested cash sweep yields are lower than money market funds
Bristol-Myers Squibb (BMY) trades on the NYSE at approximately $66.58 USD with a market capitalization of $136 billion. The biopharmaceutical company offers oncology, immunology, cardiovascular, and neuroscience medicines. BMY pays a quarterly dividend of $0.63 (3.76% yield) and carries a P/E ratio of 14.67. This guide covers BMY stock price, performance metrics, dividend dates, and the 12 best brokers to trade bmy stock.
For active equity traders interested in leveraging institutional capital without risking personal funds, exploring a comprehensive list of prop trading firms offers opportunities to trade larger positions, access advanced market tools, and earn substantial profit splits.
| Broker | Commission | Min. Deposit | Mobile App | Key Feature |
|---|---|---|---|---|
| Earn | $0 Commission | $0–$100 | iOS, Android | User-friendly, FCA regulated |
| Robinhood | $0 Commission | $0 | iOS, Android | Mobile-first, 24/5 trading |
| Yahoo Finance | Varies | Varies | iOS, Android | Free real-time quotes & charts |
| Interactive Brokers | $0–0.005/share | $0 | iOS, Android | Professional tools & low fees |
| Charles Schwab | $0 Commission | $0 | iOS, Android | Education & research tools |
| Fidelity | $0 Commission | $0 | iOS, Android | Robust research, fractional shares |
| TD Ameritrade | $0 Commission | $0 | iOS, Android | Think or Swim platform |
| Hargreaves Lansdown | 0.5%–1% | £100+ | iOS, Android | UK-focused, dividend tracking |
| Morningstar | Varies | Varies | iOS, Android | Stock ratings & analysis |
| Google Finance | N/A (Info only) | N/A | Web-based | Real-time data, portfolios |
| CNBC | N/A (News only) | N/A | Web, mobile | Breaking news & analysis |
| StockTwits | N/A (Community only) | N/A | iOS, Android | Retail sentiment, forums |
1. Earn – Best Overall Broker for BMY Trading
Earn is the top-rated broker for trading BMY stock, offering a user-friendly mobile app with zero commission fees. The platform is FCA-regulated, ensuring investor protection and compliance. No minimum deposit requirement makes it accessible to beginners and experienced traders alike.
Key Features:
- Zero commission on all BMY share trades
- Minimum deposit: $0–$100 (highly flexible)
- FCA-regulated and fully licensed
- Intuitive mobile app (iOS & Android)
- Real-time BMY price quotes & alerts
- Dividend tracking and reinvestment options
Pros:
- No hidden fees or trading commissions
- Beginner-friendly interface
- Excellent customer support
- Fast account setup (under 5 minutes)
Cons:
- Limited research tools compared to premium platforms
- No advanced charting capabilities
2. Robinhood – Best for 24/5 Trading & Low Minimums
Robinhood eliminates commissions and account minimums, enabling retail traders to buy fractional shares of BMY anytime. The platform supports extended trading hours (pre-market and after-hours), allowing positions to be opened or closed outside regular market sessions.
Key Features:
- $0 commission, $0 minimum deposit
- 24/5 extended trading on select securities
- Fractional share purchases
- Robinhood Legend advanced platform for pro traders
- Real-time BMY sentiment & insider trades visible
Pros:
- Fastest order execution for BMY
- Mobile-first design for active traders
- Transparent pricing (no hidden fees)
- 20+ million active users
Cons:
- Controversial payment-for-order-flow model
- Limited research resources
- No margin trading for newer accounts
3. Yahoo Finance – Best for Free BMY Stock Quotes & News
Yahoo Finance provides real-time BMY stock quotes, historical data, and latest BMY news without signup or fees. The platform displays BMY stock price today, charts, analyst ratings (Buy/Hold/Sell), and earnings dates. Integration with major brokers allows one-click trading.
Key Features:
- Free BMY real-time price & 20-min delayed quotes
- Advanced charting tools (5-day to 10-year timeframes)
- BMY earnings date: 29 October 2026
- Analyst price targets & recommendations
- News aggregation from 100+ financial sources
- Dividend & ex-dividend date tracking
Pros:
- Zero-cost research platform
- Mobile app (iOS/Android) synchronized with web
- Comprehensive company profile & financials
- Portfolio tracking across all brokers
Cons:
- Limited to 20-minute delayed quotes (unless subscribed)
- No built-in execution (must link external broker)
4. Interactive Brokers – Best for Professional Traders
Interactive Brokers caters to active traders seeking ultra-low commissions, advanced tools, and access to global markets. BMY trades at $0 commission for US equities, with professional-grade charting and API access for algorithmic trading.
Key Features:
- $0–0.005/share commission (lowest in industry)
- Zero minimum deposit (but $2,000 recommended)
- TWS (Trader Workstation) pro platform
- Advanced charting, backtesting, paper trading
- Multi-asset class trading (stocks, options, futures, forex)
- API support for algorithmic trading
Pros:
- Lowest per-share fees for high-volume traders
- Professional-grade tools & research
- Access to pre-market & after-hours BMY trading
- Margin rates competitive
Cons:
- Steep learning curve for beginners
- Platform cluttered with complex features
- Inactivity fee ($10/month if account unused)
Open Interactive Brokers Account
5. Charles Schwab – Best for Education & Research
Charles Schwab provides $0 commission BMY stock trading, paired with industry-leading research, educational content, and a beginner-friendly platform. The broker offers BMY stock price alerts, dividend tracking, and comprehensive company fundamentals.
Key Features:
- Zero commission on US equities (including BMY)
- StreetSmart Edge and TD Ameritrade Thinkorswim integration
- Free stock research from major Wall Street firms
- Educational webinars on dividend investing & BMY fundamentals
- Schwab Investing Insights (AI-powered analytics)
- No account minimum
Pros:
- Excellent customer service (24/7 phone & chat)
- Transparent pricing, no hidden fees
- World-class research library
- Physical branch locations for in-person support
Cons:
- Slower platform than Robinhood for active day traders
- Overwhelming feature set for true beginners
6. Fidelity – Best for Fractional Shares & Comprehensive Tools
Fidelity eliminates commissions on BMY stock trades and supports fractional share purchases, enabling investment with any dollar amount. The platform integrates portfolio analysis, retirement planning, and robust research tools into one ecosystem.
Key Features:
- $0 commission on BMY & all US equities
- Fractional shares (minimum $1 investment)
- Zero account minimum
- Fidelity Go robo-advisor (passive BMY allocation option)
- Real-time streaming data & alerts
- Tax-loss harvesting tools
- Dividend reinvestment (DRIP) automatic
Pros:
- Most trusted brand (50+ million customers)
- Comprehensive retirement planning tools
- No-fee IRAs (tax-advantaged BMY investing)
- Live customer support 24/6
Cons:
- Desktop platform less intuitive than Robinhood
- Research tools can overwhelm casual investors
7. TD Ameritrade – Best for Active Traders (Thinkorswim)
TD Ameritrade (now part of Charles Schwab) delivers zero-commission BMY stock trades via the industry-leading Thinkorswim platform. Advanced charting, options analytics, and pre/post-market trading empower active traders tracking BMY stock news today.
Key Features:
- $0 commission on stocks & ETFs (including BMY)
- Thinkorswim desktop & mobile platform
- Advanced technical analysis & scanning
- Pre-market (7am ET) & after-hours (8pm ET) BMY trading
- Options strategies & visualizations
- No minimum deposit required
Pros:
- Thinkorswim is #1 platform for active traders
- Paper trading (risk-free practice account)
- Excellent charting & technical analysis tools
- Strong mobile app execution
Cons:
- Thinkorswim has steep learning curve
- No fractional shares (minimum 1 share of BMY)
- Customer service sometimes slow
8. Hargreaves Lansdown – Best UK-Based Broker for BMY
Hargreaves Lansdown specializes in UK investors trading US stocks, including BMY. The platform charges 0.5%–1% commission, but offers superior dividend tracking, tax reporting for UK accounts, and GBP currency options.
Key Features:
- Commission: 0.5% (capped at £12.50 per trade)
- Minimum deposit: £100+ (flexible)
- Dividend reinvestment (DRIP) available
- Tax-efficient ISA wrapper for UK investors
- Real-time BMY prices in GBP
- Ex-dividend date alerts (02 July 2026 next ex-date)
Pros:
- Specifically designed for UK-based investors
- Currency hedging options (avoid FX volatility)
- Excellent dividend tracking & reinvestment
- No account minimum (low barriers to entry)
Cons:
- Commission higher than US brokers ($0)
- Limited research tools vs. Fidelity/Schwab
- Slower execution speeds during US market hours
Open Hargreaves Lansdown Account
9. Morningstar – Best for Stock Research & Ratings
Morningstar is a research-only platform offering BMY stock price quote, analyst ratings, fundamental metrics, and peer comparisons. The site displays BMY valuation (fair value estimate), bull/bear arguments, and quarterly earnings forecasts—ideal for research-driven investors.
Key Features:
- Free BMY stock quote & real-time price
- Morningstar analyst rating (Bull/Hold/Bear consensus)
- Fair-value estimate vs. current price
- Industry comparables (vs. AbbVie, Merck, Pfizer)
- Quarterly earnings & dividend tracking
- Company report (strategy, management, risks)
- Premium membership for deeper analysis ($199/year)
Pros:
- Unbiased analyst research (not beholden to sales)
- Excellent peer comparison tools
- Comprehensive financial statements & ratios
- Free access (premium optional)
Cons:
- Cannot execute trades (research only)
- Price quotes delayed 15–20 minutes (free tier)
- Interface clunky compared to Yahoo Finance
Go to Morningstar BMY Research
10. Google Finance – Best for Integrated Portfolio & News
Google Finance provides real-time BMY stock price, historical charts, news feeds, and insider trading activity. The platform integrates seamlessly with Google Search, Calendar, and Gmail, enabling quick lookups and price alerts without leaving Google's ecosystem.
Key Features:
- Real-time BMY:NYSE quotes (no delay)
- 5-year historical price chart & trend analysis
- Related stocks: PFE (Pfizer), AZN (AstraZeneca), ABBV (AbbVie)
- Key stats: Market cap ($136B), P/E (14.67), Dividend (3.76%)
- News aggregation (CNBC, Reuters, Bloomberg)
- Insider trading activity & SEC filings
- Portfolio sync across Google accounts
Pros:
- Zero-cost research (Google account required)
- Seamless mobile & desktop experience
- Fastest news updates (aggregates major outlets)
- No signup; works with existing Google login
Cons:
- No trading functionality (research only)
- Limited technical analysis tools
- Data sometimes lagging 1–2 minutes
11. CNBC – Best for Breaking BMY News & Analyst Commentary
CNBC delivers real-time BMY stock news today, market analysis, and exclusive interviews with Bristol-Myers executives and Wall Street analysts. Track merger rumors (AstraZeneca deal talks), FDA approvals, patent challenges, and earnings surprises as they break.
Key Features:
- Breaking news alerts (email & push notifications)
- Live market coverage (6:30am–5pm ET weekdays)
- Analyst commentary on BMY fundamentals & valuation
- Earnings call transcripts & guidance updates
- Video segments on BMY product pipeline (Opdivo, Eliquis, Cobenfy)
- Insider trading reports & stock sales by management
Pros:
- Fastest news delivery (minutes after announcements)
- Expert commentary from veteran anchors
- Video library searchable by BMY ticker
- Free access (CNBC.com, cable TV, apps)
Cons:
- News-only platform (no trading or portfolio tools)
- Ads/paywalls for premium content
- Mobile app notifications can be excessive
12. StockTwits – Best for Retail Sentiment & Community Discussion
StockTwits aggregates BMY stock news, charts, and real-time discussion threads from 100,000+ retail traders. View bullish/bearish sentiment percentages, insider activity alerts, and crowdsourced analysis to understand retail trader positioning on BMY.
Key Features:
- Real-time BMY sentiment: 61% Bearish (current)
- Message board: 50,000+ discussions on BMY strategy
- Watchlist & portfolio tracking (mobile-first app)
- Streaming price charts & technical indicators
- Insider trading alerts (CEO, CFO stock sales)
- Earnings date calendar & fundamental metrics
- Free ChatGPT integration for analysis
Pros:
- Authentic retail sentiment (not professional analysts)
- Active community (millions of posts daily)
- Mobile app highly responsive & intuitive
- Zero cost (ads-supported model)
Cons:
- Sentiment can be manipulative (pump-and-dump schemes)
- No trade execution (info only)
- Misinformation common in forums
Sponsored Content
NeOstRoyComA is an initiative launched by former market research analysts previously affiliated with Funded Engineer. The platform maintains a dynamic top-15 Forex prop trading firm directory, meticulously reviewing and refreshing its rankings of the leading 15 FX proprietary firms each year.
Furthermore, although not openly advertised directly on the site, the project shares proprietary "engineered trading strategies" crafted for retail and prop traders. The creators describe these systems as finely tuned tactical frameworks built to help participants smoothly clear evaluation challenges, while also supporting systematic trading across equities, CFDs, and currency pairs. Access is granted through an exclusive distribution process: a single-use link sent directly via SMS. Interested traders simply submit a request through the contact form, confirm via email correspondence with the team, and receive their personalized strategy link.
At the time of writing, strategy access is priced at 99 USDT. This discreet, invite-only delivery model is intentionally implemented to safeguard algorithmic methods from exposure and prevent prop firms and brokerages from blacklisting high-performing execution models.
How We Ranked These BMY Brokers & Platforms
We evaluated 12 platforms for trading and researching BMY stock across six criteria: (1) Commission fees ($0 vs. percentage-based), (2) Minimum deposit requirements, (3) Platform usability (mobile & desktop UX), (4) Real-time data quality (price quotes, charts, news feeds), (5) Customer support (response time, expertise), and (6) Research tools (analyst ratings, comparables, technical analysis). We prioritized brokers offering zero-commission BMY trades, verified features through official websites & user reviews, and confirmed current pricing as of August 2026. For research-only platforms, we assessed data accuracy and integration with major brokers.
BMY Stock Key Metrics & Performance
Real-Time BMY Price Data (As of August 28, 2026):
- Current Price: $66.58 USD
- Daily Change: –$0.37 (–0.55%)
- After-Hours: $66.47 (–0.17%)
- 52-Week High: $68.64 (August 19, 2026)
- 52-Week Low: $42.52 (October 29, 2025)
- Market Capitalization: $136.00 billion
- Trading Volume: 5.54 million shares (today); avg. 11.97 million
BMY Financial Metrics:
- P/E Ratio: 14.67 (below healthcare sector avg. of ~16)
- Earnings Per Share (EPS): $4.54 (TTM)
- Profit Margin: 18.87% (net); 25.57% (Q2 FY26)
- Return on Equity (ROE): 46.60%
- Total Revenue (TTM): $49.19 billion
- Net Income (TTM): $9.28 billion
- Free Cash Flow (TTM): $8.11 billion (levered)
- Beta (5Y): 0.22 (low volatility vs. market)
BMY Dividend Information & Ex-Dividend Dates
Quarterly Dividend Details:
- Quarterly Dividend Per Share: $0.63
- Annual Dividend Yield: 3.76%–3.78%
- Forward Dividend & Yield: $2.52 (3.76%)
- Last Ex-Dividend Date: July 2, 2026
- Last Payment Date: August 3, 2026
- Next Ex-Dividend Date: ~October 2026 (estimated)
- Dividend Growth: BMY has consistently raised dividends for 10+ years
